Novel mechanism of resistance to targeted therapies in lung cancer by Walter Wang, David P. Carbone, Rajeswara Rao Arasada

Get full text

Sonic hedgehog pathway expression in non-small cell lung cancer by Malvi Savani, Yan Guo, David P. Carbone, Ildiko Csiki

Get full text

Long-term Smoking Mediated Down-regulation of Smad3 Induces Resistance to Carboplatin in Non-Small Cell Lung Cancer by Debangshu Samanta, Jacob Kaufman, David P. Carbone, Pran K. Datta

Get full text

Real-world patient characteristics and treatment patterns in US patients with advanced non-small cell lung cancer by Hozefa A. Divan, Marisa A. Bittoni, Ashok Krishna, David P. Carbone

Get full text

Specific Targeting of Notch Ligand-Receptor Interactions to Modulate Immune Responses: A Review of Clinical and Preclinical Findings by Mounika U. L. Goruganthu, Anil Shanker, Anil Shanker, Mikhail M. Dikov, David P. Carbone

Get full text

ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC): PATIENTS’ ILLNESS PERCEPTIONS AT DIAGNOSIS by Stephen B. Lo, Peter G. Shields, David P. Carbone, Carolyn J. Presley, Barbara L. Andersen

Get full text

Real-world first-line treatment and overall survival in non-small cell lung cancer without known EGFR mutations or ALK rearrangements in US community oncology setting. by Amy P Abernethy, Ashwini Arunachalam, Thomas Burke, Caroline McKay, Xiting Cao, Rachael Sorg, David P Carbone

Get full text

Metabolic reprogramming by adenosine antagonism and implications in non-small cell lung cancer therapy by Shuxiao Guan, Shankar Suman, Joseph M. Amann, Ruohan Wu, David P. Carbone, Jie Wang, Mikhail M. Dikov

Get full text

Linear Endobronchial Ultrasound in the Era of Personalized Lung Cancer Diagnostics—A Technical Review by Filiz Oezkan, Stephan Eisenmann, Kaid Darwiche, Asmae Gassa, David P. Carbone, Robert E. Merritt, Peter J. Kneuertz

Get full text

DLL3: an emerging target in small cell lung cancer by Dwight H. Owen, Michael J. Giffin, Julie M. Bailis, Marie-Anne Damiette Smit, David P. Carbone, Kai He

Get full text

Global Transcriptome Analysis of RNA Abundance Regulation by ADAR in Lung Adenocarcinoma by Michael F. Sharpnack, Bin Chen, Dvir Aran, Idit Kosti, Douglas D. Sharpnack, David P. Carbone, Parag Mallick, Kun Huang

Get full text

Elucidating the Mechanism of Regulation of Transforming Growth Factor β Type II Receptor Expression in Human Lung Cancer Cell Lines by Sunil K. Halder, Yong-Jig Cho, Arunima Datta, Govindaraj Anumanthan, Amy-Joan L. Ham, David P. Carbone, Pran K. Datta

Get full text

Cost-Effectiveness Analysis of Nivolumab Plus Ipilimumab vs. Chemotherapy as First-Line Therapy in Advanced Non-Small Cell Lung Cancer by Huabin Hu, Huabin Hu, Longjiang She, Mengting Liao, Yin Shi, Linli Yao, Dong Ding, Youwen Zhu, Shan Zeng, David P. Carbone, Jin Huang

Get full text

Depression in association with neutrophil-to-lymphocyte, platelet-to-lymphocyte, and advanced lung cancer inflammation index biomarkers predicting lung cancer survival. by Barbara L Andersen, John Myers, Tessa Blevins, Kylie R Park, Rachel M Smith, Sarah Reisinger, David P Carbone, Carolyn J Presley, Peter G Shields, William E Carson

Get full text

Durable responders in advanced NSCLC with elevated TMB and treated with 1L immune checkpoint inhibitor: a real-world outcomes analysis by David P Carbone, David Spigel, Jeffrey S Ross, Karthikeyan Murugesan, Gerald Li, Richard S P Huang, Ryon P Graf, Geoffrey R Oxnard, Alexa Schrock, Liangliang Zhang, Khaled Tolba, Jacob Sands

Get full text

Longitudinal plasma proteomic profiling of patients with non-small cell lung cancer undergoing immune checkpoint blockade by David P Carbone, Jair Bar, Alona Zer, Yuval Shaked, Michal Harel, Coren Lahav, Eyal Jacob, Ofer Sharon, Nili Dahan, Itamar Sela, Yehonatan Elon, Galit Yahalom, Iris Kamer, Adam P Dicker, Shani Raveh Shoval

Get full text

Identifying patterns of care for elderly patients with non-surgically treated stage III non-small cell lung cancer: an analysis of the national cancer database by Eric D Miller, James L Fisher, Karl E Haglund, John C Grecula, Meng Xu-Welliver, Erin M Bertino, Kai He, Peter G Shields, David P Carbone, Terence M Williams, Gregory A Otterson, Jose G Bazan

Get full text

Acquired Resistance of EGFR-Mutant Lung Adenocarcinomas to Afatinib plus Cetuximab Is Associated with Activation of mTORC1 by Valentina Pirazzoli, Caroline Nebhan, Xiaoling Song, Anna Wurtz, Zenta Walther, Guoping Cai, Zhongming Zhao, Peilin Jia, Elisa de Stanchina, Erik M. Shapiro, Molly Gale, Ruonan Yin, Leora Horn, David P. Carbone, Philip J. Stephens, Vincent Miller, Scott Gettinger, William Pao, Katerina Politi

Get full text

An immunogold single extracellular vesicular RNA and protein (AuSERP) biochip to predict responses to immunotherapy in non‐small cell lung cancer patients by Luong T. H. Nguyen, Jingjing Zhang, Xilal Y. Rima, Xinyu Wang, Kwang Joo Kwak, Tamio Okimoto, Joseph Amann, Min Jin Yoon, Takehito Shukuya, Chi‐Ling Chiang, Nicole Walters, Yifan Ma, Donald Belcher, Hong Li, Andre F. Palmer, David P. Carbone, L. James Lee, Eduardo Reátegui

Get full text

Retraction Note: AKT3-mediated IWS1 phosphorylation promotes the proliferation of EGFR-mutant lung adenocarcinomas through cell cycle-regulated U2AF2 RNA splicing by Georgios I. Laliotis, Evangelia Chavdoula, Maria D. Paraskevopoulou, Abdul Kaba, Alessandro La Ferlita, Satishkumar Singh, Vollter Anastas, Keith A. Nair, Arturo Orlacchio, Vasiliki Taraslia, Ioannis Vlachos, Marina Capece, Artemis Hatzigeorgiou, Dario Palmieri, Christos Tsatsanis, Salvatore Alaimo, Lalit Sehgal, David P. Carbone, Vincenzo Coppola, Philip N. Tsichlis

Get full text